US Biotech Fathom Therapeutics Raises $55M, Expands to Greece with Kos Support

Fathom Therapeutics, a US biotech, has raised $55 million in Series A funding led by Sutter Hill Ventures with participation from Kos Biotechnology Partners, and is opening an office in Greece. The move signals international expansion and investor confidence in the company's pipeline, though specific therapeutic focus remains undisclosed. This is a routine corporate development with limited immediate market impact.

AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works